Search

Floyd H Chilton

from Pilot Mountain, NC
Deceased
Get Report
Related to:
Candice M Chilton, 40Ann M Chilton, 69Tanya Donnette Chilton, 58Shane P Chilton, 34Ruby J Chilton, 91Dewey R Rodgers, 88Roger Dale Chilton, 69Ski ChiltonSusan A Chilton, 65Clio ChiltonEliane Rodgers, 87Hector Lopez, 59Matthew Chilton, 46F H Chilton, 66Sarah M Chilton, 30Rdale Chilton
Connected to:
Alexander B Chilton, 41Autumn B Chilton, 44Crystal D Chilton, 41Fred G Chilton, 86Kirby C Chilton, 70Logan D Chilton, 36Mandy A Chilton, 46Stacey M Chilton, 38Vikram Chilukoti, 40Soni S Chilukuri, 57

Floyd Chilton Phones & Addresses

  • 804 Sunset Dr, Pilot Mountain, NC 27041
  • 4226 Allistair Rd, Winston Salem, NC 27104
  • King, NC

Work

Company: The university of arizona Aug 2018 Position: Professor nutritional sci; director precision nutrition and wellness initiative; assoc director bio5 institute

Education

School / High School: University of Colorado School of Medicine 1984 to 1986 Specialities: Pharmacology

Skills

Biochemistry • Pharmacology • Research • Science • Physiology • Life Sciences • Molecular Biology • Cell Biology • Biotechnology • Lifesciences • Cell Culture • Nutrition • Data Analysis • Neuroscience • Medicine • Cancer • Public Health • Translational Research • Leadership • Drug Discovery • Entrepreneur • Western Blotting • Elisa • Pcr • Animal Models • Genomics • Broadcast • Genetics • Public Speaking • Nonprofit Organizations • Biomedical Researcher • Author • Inventor • Professor • Scientists • Scientist

Interests

Overcome Fears • Children • Experience Emotional Healing • Economic Empowerment • Civil Rights and Social Action • Poverty Alleviation • Science and Technology • Win the War Within (Rodale) • Disaster and Humanitarian Relief • Human Rights • Health

Industries

Higher Education

Resumes

Resumes

Floyd Chilton Photo 1

Professor Nutritional Sci; Director Precision Nutrition And Wellness Initiative; Assoc Director Bio5 Institute

View page
Location:
4226 Allistair Rd, Winston Salem, NC 27104
Industry:
Higher Education
Work:
The University of Arizona
Professor Nutritional Sci; Director Precision Nutrition and Wellness Initiative; Assoc Director Bio5 Institute
Wake Forest Baptist Health 1992 - Aug 2018
Professor of Physiology and Pharmacology and Cancer Biology
Genesmart 2009 - 2016
Senior Consultant
Pilot Therapeutics Dec 2001 - Nov 2002
President and Chief Executive Officer
Johns Hopkins Hospital Jun 1986 - Jun 1992
Assistant Professor
Education:
University of Colorado School of Medicine 1984 - 1986
Wake Forest School of Medicine 1980 - 1984
Doctorates, Doctor of Philosophy, Biochemistry, Philosophy Western Carolina University 1977 - 1980
Bachelors, Biology, Chemistry
Skills:
Biochemistry
Pharmacology
Research
Science
Physiology
Life Sciences
Molecular Biology
Cell Biology
Biotechnology
Lifesciences
Cell Culture
Nutrition
Data Analysis
Neuroscience
Medicine
Cancer
Public Health
Translational Research
Leadership
Drug Discovery
Entrepreneur
Western Blotting
Elisa
Pcr
Animal Models
Genomics
Broadcast
Genetics
Public Speaking
Nonprofit Organizations
Biomedical Researcher
Author
Inventor
Professor
Scientists
Scientist
Interests:
Overcome Fears
Children
Experience Emotional Healing
Economic Empowerment
Civil Rights and Social Action
Poverty Alleviation
Science and Technology
Win the War Within (Rodale)
Disaster and Humanitarian Relief
Human Rights
Health

Business Records

Name / Title
Company / Classification
Phones & Addresses
Floyd E Chilton
Vice President,Secretary
CHILTON-STUART ENTERPRISES, INC

Publications

Us Patents

Compositions, Methods, And Kits For Polyunsaturated Fatty Acids From Microalgae

View page
US Patent:
8343753, Jan 1, 2013
Filed:
May 6, 2009
Appl. No.:
12/436542
Inventors:
Floyd Chilton - Winston Salem NC, US
Fan Lu - Clemmons NC, US
Assignee:
Wake Forest University School of Medicine - Winston-Salem NC
International Classification:
C12N 1/12
US Classification:
4352571
Abstract:
The present invention provides compositions, methods, and kits comprising PUFAs produced by microalgae, in particular omega-3 and/or omega-6 fatty acids produced by members of the genus , in particular. The invention also provides compositions, methods, and kits comprising the PUFAs for the prophylactic and/or therapeutic treatment of a disease or condition, in particular a cardiovascular and/or inflammatory disease or condition.

Beta Lactams As Antiproliferative Agents

View page
US Patent:
20020082250, Jun 27, 2002
Filed:
Jan 28, 2000
Appl. No.:
09/423420
Inventors:
JAMES DAVID WINKLER - FORT WASHINGTON PA, US
FLOYD HAROLD CHILTON III - PILOT MOUNTAIN NC, US
International Classification:
A61K031/397
A01N043/00
US Classification:
514/210020
Abstract:
This invention relates to a method of treating or reducing cell proliferation in a mammal in need thereof which comprises administering to said mammal an effective CoA-independent transacylase (CoA-IT) inhibiting amount of a compound of formula (I), wherein the variables of Y, X, m, R 3, R 4, R 10, R 20, R 5, R 6 and R 7 are defined in the specification. FIG. demonstrates the ability of SB216754, ((3S,4R)-4-(isobutenyloxy)-3-triphenylmethylamino)azetidin-2-one) to decrease the viability of HL-60 cells.

Fatty Acid-Containing Emulsion With Increased Bioavailability

View page
US Patent:
20020188024, Dec 12, 2002
Filed:
Jan 31, 2002
Appl. No.:
10/066334
Inventors:
Floyd Chilton - Winston-Salem NC, US
Marc Surette - Winston-Salem NC, US
Iphigenia Koumenis - Winston-Salem NC, US
International Classification:
A61K031/202
US Classification:
514/560000
Abstract:
Compositions for the treatment of symptoms of inflammatory disorders may include gamma-linolenic acid or dihomogammalinolenic acid, an inhibitor of desaturase, and optionally stearidonic acid or -3 arachidonic acid. Preferred formulations may be in the form of a good tasting, preferably milk or fruit based drink, or a dried powder. Compositions reduce inflammation and inhibit increase in serum arachidonic acid associated with gamma-linolenic acid.

Fatty Acid-Containing Compositions And Methods For The Treatment Of Cytokine Mediated Disorders

View page
US Patent:
20060052446, Mar 9, 2006
Filed:
Jan 31, 2003
Appl. No.:
10/503552
Inventors:
Floyd Chilton - Winston-Salem NC, US
Marc Surette - Moncton, CA
Iphigenia Koumenis - Winston-Salem NC, US
Kenneth Tramposch - East Amherst NY, US
International Classification:
A61K 31/235
A61K 31/20
US Classification:
514543000, 514587000, 514560000
Abstract:
Compositions, dietary supplements and medical foods for the treatment of symptoms of inflammatory disorders may include gamma-linolenic acid or dihomogammalinolenic acid, an inhibitor of Δdesaturase, and optionally stearidonic acid or ω−3 arachidonic acid. Preferred formulations may be in the form of a good tasting, preferably milk or fruit based drink, or a dried powder. Compositions reduce inflammation and inhibit increase in serum arachidonic acid associated with gamma-linolenic acid. The compositions of the invention may also be used for the treatment of cytokine mediated disorders in patients in need thereof.

Compositions And Methods For Prevention And Treatment Of Mammalian Diseases

View page
US Patent:
20100010088, Jan 14, 2010
Filed:
Oct 29, 2008
Appl. No.:
12/260134
Inventors:
Floyd Chilton - Winston Salem NC, US
Fan Lu - Clemmons NC, US
Assignee:
Wake Forest University School of Medicine - Winston Salem NC
International Classification:
A61K 31/20
C11B 1/00
C12P 7/64
A23K 1/00
A23D 7/00
A23K 1/18
A23L 1/32
A23C 9/00
A23L 1/31
A01K 67/00
US Classification:
514560, 554 8, 435134, 426 7, 426601, 426 2, 426614, 426580, 426641, 800 8
Abstract:
The present invention discloses processes of making a polyunsaturated fatty acid compositions, and compositions thereof. Thus, one method of making a polyunsaturated fatty acid compositions comprises at least 8% polyunsaturated fatty acids, the process comprising extracting the fatty acids from a microalgae, wherein the fatty acids can be (a) GLA in an amount of 1% to 10% of total fatty acids; (b) SDA in an amount of 5% to 50% of total fatty acids; (c) EPA in an amount of 2% to 30% of total fatty acids, and (d) DHA in an amount of 2% to 30% of total fatty acids, wherein a polyunsaturated fatty acid composition is produced comprising at least 8% polyunsaturated fatty acids. Additional processes of making polyunsaturated fatty acid compositions, animal feed additives, and animal products are disclosed and the compositions, feed additives and products thereof.

Methods And Compositions For Correlating Genetic Markers With Conversion Of Medium Chain Polyunsaturated Fatty Acids To Long Chain Polyunsaturated Fatty Acids

View page
US Patent:
20110287975, Nov 24, 2011
Filed:
May 13, 2011
Appl. No.:
13/107261
Inventors:
Floyd H. Chilton - Clemmons NC, US
Rasika A. Mathias - Ellicott City MD, US
International Classification:
C40B 30/10
US Classification:
506 12
Abstract:
The present invention provides methods of identifying a subject having an increased or decreased ability to convert medium chain-polyunsaturated fatty acids (MC-PUFAs) to long chain polyunsaturated fatty acids (LC-PUFAs), comprising: (a) correlating the presence of one or more than one genetic marker in chromosome 11ql2-13, between build 37.1 position 61548559 and build 37.1 position 61560261, with an increased ability to convert MC-PUFAs to LC-PUFAs; and b) detecting the one or more than one genetic marker of step (a) in the subject, thereby identifying the subject as having an increased ability to convert MC-PUFAs to LC-PUFAs. Also provided are methods of correlating one or more genetic markers with an ability to convert MC-PUFAs to LC-PUFAs.

Dietary Control Of Arachidonic Acid Metabolism

View page
US Patent:
61073342, Aug 22, 2000
Filed:
Feb 23, 1998
Appl. No.:
9/028256
Inventors:
Floyd H. Chilton - Pilot Mountain NC
Assignee:
Wake Forest University - Winston-Salem NC
International Classification:
A61K 3136
A61K 3120
A61K 3112
US Classification:
514464
Abstract:
The present invention is directed towards the control of inflammation. More specifically there are provided herein dietary fatty acid regimens that may be used to inhibit the increase of serum arachidonic acid when GLA is provided as a dietary supplement.

Anti-Inflammatory Compounds

View page
US Patent:
54708826, Nov 28, 1995
Filed:
Jun 2, 1994
Appl. No.:
8/252716
Inventors:
James S. Dixon - Malvern PA
Raplh F. Hall - Villanova PA
Lisa A. Marshall - Wyndmoor PA
Floyd H. Chilton - Pilot Mountain NC
Ruth J. Mayer - Wayne PA
James D. Winkler - Fort Washington PA
Assignee:
SmithKline Beecham Corp. - Philadelphia PA
International Classification:
A01N 4728
US Classification:
514596
Abstract:
This invention relates to the novel pharmaceutical compositions of Formulas (I) and (II) each of which comprises a compound of Formula (I) or (II) and a pharmaceutically acceptable diluent or carrier. This invention also relates to a method of treating or reducing inflammation in a mammal in need thereof, which comprises administering to said mammal an effective amount of a compound or composition of Formula (I) or (II).

Isbn (Books And Publications)

Inflammation Nation : The First Clinically Proven Eating Plan to End Our Nation's Secret Epidemic

View page
Author

Floyd H. Chilton

ISBN #

0743269640

Inflammation Nation: The First Clinically Proven Eating Plan to End Our Nation's Secret Epidemic

View page
Author

Floyd H. Chilton

ISBN #

0743269659

Control profile
Floyd H Chilton from Pilot Mountain, NCDeceased Get Report